[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

[@OncoThor](/creator/twitter/OncoThor)
"On my NET PubMed radar this morning from @rohit_thum et al. at MSKCC. DLL3 positive in XX% of GEPNECs and XX% of well diff G3 panc NETs and DLL3+ was associated with worse outcomes in that group. Check it out @lisabodei @DianeReidyLagun @natasharekhtman"  
![@OncoThor Avatar](https://lunarcrush.com/gi/w:16/cr:twitter::814218641579376641.png) [@OncoThor](/creator/x/OncoThor) on [X](/post/tweet/1946188479005589987) 2025-07-18 12:41:06 UTC 5039 followers, 3424 engagements


"@ClayReedMD @OzzyOsbourne I so wish I had seen him live. You may enjoy the obit in NY Times. Brilliantly written and Ozzy would have loved it"  
![@OncoThor Avatar](https://lunarcrush.com/gi/w:16/cr:twitter::814218641579376641.png) [@OncoThor](/creator/x/OncoThor) on [X](/post/tweet/1948077929620976009) 2025-07-23 17:49:06 UTC 5043 followers, XX engagements


"@rohit_thum @AnisToumeh @lisabodei @DianeReidyLagun @natasharekhtman I agree and second the comment on Amgen. We have treated a few pts with NECs but not yet a G3 NET patient but we are routinely staining for DLL3 now. Also agree with the comment on the DLL3 threshold. With obrixtamig XX% threshold may be reasonable right @Ja_Capdevila"  
![@OncoThor Avatar](https://lunarcrush.com/gi/w:16/cr:twitter::814218641579376641.png) [@OncoThor](/creator/x/OncoThor) on [X](/post/tweet/1946214136783794270) 2025-07-18 14:23:03 UTC 5043 followers, XXX engagements